Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07304063 · ClinicalTrials.gov registry record · NA
Overcoming Barriers to Uptake of Cascade Screening
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07304063 is a NA study that has not yet begun recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 20 participants.
The verdict
NCT07304063, a NA study, has not yet begun recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Lynch syndrome is a genetic condition that increases cancer risk. The public health impact of genetic testing for disease prevention hinges on cascade screening, which is the systematic identification and testing of blood relatives after a family member has been diagnosed with a genetic condition. Despite its importance in disease prevention, only half of first-degree relatives of individuals with Lynch syndrome undergo cascade screening. To address this gap, the study will pilot test an online version of Let's Talk, a novel intervention designed to support and promote cascade screening. This intervention tool is designed to support and encourage more family members to get screened. The purpose of this study aim is to assess the feasibility of the online Let's Talk tool in clinical use by examining implementation and effectiveness outcomes related to the use of the planning tool across three clinics at a large academic-affiliated medical center with patients (n=15) seen by one of five genetic counselors (n=5).
Interventions
- BEHAVIORAL Let's Talk Genetics Providers
- BEHAVIORAL Let's Talk Patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07304063
The ClinicalTrials.gov registry entry for NCT07304063 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Let's Talk Genetics Providers is the first listed.
NCT07304063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07304063 about?
NCT07304063 is a clinical study titled "Overcoming Barriers to Uptake of Cascade Screening". Lynch syndrome is a genetic condition that increases cancer risk. The public health impact of genetic testing for disease prevention hinges on cascade screening, which is the systematic identification and testing of blood relatives after a family member has been diagnosed with a genetic condition. D...
What is the current status of trial NCT07304063?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-07. Estimated completion is 2026-10.
What interventions are being tested in trial NCT07304063?
The interventions under investigation include: Let's Talk Genetics Providers (BEHAVIORAL), Let's Talk Patients (BEHAVIORAL).
Who is sponsoring clinical trial NCT07304063?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.